These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6846655)

  • 1. More on the fallibility of the double-blind.
    Barsa JA
    Am J Psychiatry; 1983 Jun; 140(6):820-1. PubMed ID: 6846655
    [No Abstract]   [Full Text] [Related]  

  • 2. The double-blind in danger: untoward consequences of informed consent.
    Brownell KD; Stunkard AJ
    Am J Psychiatry; 1982 Nov; 139(11):1487-9. PubMed ID: 6753613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind assessment of therapeutic efficacy in clinical trials.
    Cohen S
    Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 5. [How blind is a double-blind trial really? Validity of controlled investigations].
    Modestin J; Hodel J
    Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug side effects and the double-blind design.
    Robinson ML
    Am J Psychiatry; 1988 Apr; 145(4):539. PubMed ID: 3348469
    [No Abstract]   [Full Text] [Related]  

  • 7. Blindness and the validity of the double-blind procedure.
    Hughes JR; Krahn D
    J Clin Psychopharmacol; 1985 Jun; 5(3):138-42. PubMed ID: 3998203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How blind is double-blind? A study of fish oil versus placebo.
    Damico KE; Stoll AL; Marangell LB; Cohen BM
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):393-5. PubMed ID: 12054908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The randomized clinical trial: a prerequisite for rational therapy.
    Staquet M
    Eur Urol; 1976; 2(6):265-70. PubMed ID: 829222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine.
    Rabkin JG; Markowitz JS; Stewart J; McGrath P; Harrison W; Quitkin FM; Klein DF
    Psychiatry Res; 1986 Sep; 19(1):75-86. PubMed ID: 3538107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing the boat: competence and consent in psychiatric research.
    Appelbaum PS
    Am J Psychiatry; 1998 Nov; 155(11):1486-8. PubMed ID: 9812106
    [No Abstract]   [Full Text] [Related]  

  • 12. A psychological perspective for double-blind trials.
    Zifferblatt SM; Wilbur CS
    Clin Pharmacol Ther; 1978 Jan; 23(1):1-10. PubMed ID: 618704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge to psychiatry as society's agent for mental illness treatment and research.
    Carpenter WT
    Am J Psychiatry; 1999 Sep; 156(9):1307-10. PubMed ID: 10484937
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the psychiatric and social implications of sensitivity training.
    Malcolm AI
    Can Psychiatr Assoc J; 1973 Dec; 18(6):527-31. PubMed ID: 4761163
    [No Abstract]   [Full Text] [Related]  

  • 16. ['Informed consent' and prerandomization].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1301-3. PubMed ID: 10918907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is your 'double-blind' design truly double-blind?
    Oxtoby A; Jones A; Robinson M
    Br J Psychiatry; 1989 Nov; 155():700-1. PubMed ID: 2611601
    [No Abstract]   [Full Text] [Related]  

  • 18. [Informed consent of patients in psychiatry. Consequences in biomedical research].
    Poirier-Littré MF
    Encephale; 1990; 16(4):277-9. PubMed ID: 2209482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing informed consent for research and treatment.
    Dunn LB; Jeste DV
    Neuropsychopharmacology; 2001 Jun; 24(6):595-607. PubMed ID: 11331139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Randomization, informed consent and double-blind].
    Navarro FA; López-Gil JA
    Med Clin (Barc); 1992 Jan; 98(2):78. PubMed ID: 1545635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.